Cargando…

Antibody-mediated prevention and treatment of HIV-1 infection

Novel broadly neutralizing antibodies targeting HIV-1 hold promise for their use in the prevention and treatment of HIV-1 infection. Pre-clinical results have encouraged the evaluation of these antibodies in healthy and HIV-1-infected humans. In first clinical trials, highly potent broadly neutraliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruell, Henning, Klein, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240265/ https://www.ncbi.nlm.nih.gov/pubmed/30445968 http://dx.doi.org/10.1186/s12977-018-0455-9

Ejemplares similares

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
por: LaMont, Colin, et al.
Publicado: (2022)

Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies
por: Kreer, Christoph, et al.
Publicado: (2020)

CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention
por: Vanshylla, Kanika, et al.
Publicado: (2021)

Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
por: Kalusche, Sarah, et al.
Publicado: (2020)

Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
por: Niessl, Julia, et al.
Publicado: (2020)

Contact-dependent inhibition of HIV-1 replication in ex vivo human tonsil cultures by polymorphonuclear neutrophils
por: Reif, Tatjana, et al.
Publicado: (2021)

Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection
por: Parsons, Matthew S, et al.
Publicado: (2018)

Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
por: Kreer, Christoph, et al.
Publicado: (2023)

Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis
por: Malin, Jakob J, et al.
Publicado: (2023)

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
por: Schommers, Philipp, et al.
Publicado: (2020)

SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
por: Gruell, Henning, et al.
Publicado: (2022)

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
por: Schoofs, Till, et al.
Publicado: (2019)

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
por: Gilbert, Peter B., et al.
Publicado: (2022)

Nanosystems Applied to HIV Infection: Prevention and Treatments
por: Macchione, Micaela A., et al.
Publicado: (2020)

Antibody therapies for the prevention and treatment of viral infections
por: Salazar, Georgina, et al.
Publicado: (2017)

Relationship between intact HIV-1 proviruses in circulating CD4(+) T cells and rebound viruses emerging during treatment interruption
por: Lu, Ching-Lan, et al.
Publicado: (2018)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
por: Wagh, Kshitij, et al.
Publicado: (2016)

HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
por: Cohen, Myron S., et al.
Publicado: (2012)

Engineering antibody-like inhibitors to prevent and treat HIV-1 infection
por: Gardner, Matthew R., et al.
Publicado: (2017)

Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection
por: Förster, Beatrix, et al.
Publicado: (2018)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
por: Tober-Lau, Pinkus, et al.
Publicado: (2022)

A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
por: Zhao, Alexa Vyain, et al.
Publicado: (2022)

Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date
por: Whitfield, Thomas, et al.
Publicado: (2016)

Combination therapy with anti-HIV-1 antibodies maintains viral suppression
por: Mendoza, Pilar, et al.
Publicado: (2018)

HIV treatment for prevention
por: Ambrosioni, Juan, et al.
Publicado: (2011)

Antibody-mediated Prevention of Fusarium Mycotoxins in the Field
por: Hu, Zu-Quan, et al.
Publicado: (2008)

Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis
por: Phelps, Meredith, et al.
Publicado: (2021)

Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections
por: Merkuleva, Yu. A., et al.
Publicado: (2022)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
por: Braibant, Martine, et al.
Publicado: (2013)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
por: Parsons, Matthew S., et al.
Publicado: (2018)

HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells
por: Stab, Viktoria, et al.
Publicado: (2023)

The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany
por: Meyer, Meike, et al.
Publicado: (2021)

Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
por: Bar-On, Yotam, et al.
Publicado: (2018)

COVID‐19 complicated by parainfluenza co‐infection in a patient with chronic lymphocytic leukemia
por: Langerbeins, Petra, et al.
Publicado: (2020)

HIV Treatment as Prevention: Natural Experiments Highlight Limits of Antiretroviral Treatment as HIV Prevention
por: Wilson, David P.
Publicado: (2012)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_np1dh1ok89g8nj3po6uhn5kpk3